Intellectual Property, Pharmaceuticals and Public Health

Access to Drugs in Developing Countries

Kenneth C. Shadlen, Samira Guennif, Alenka Guzmán, Narayanan Lalitha (Herausgeber)

Buch | Hardcover

352 Seiten

2011
Edward Elgar Publishing Ltd (Verlag)
978-1-84980-014-3 (ISBN)

Artikel merken

This up-to-date book examines pharmaceutical development, access to medicines, and the protection of public health in the context of two fundamental changes that the global political economy has undergone since the 1970s, the globalization of trade and production and the increased harmonization of national regulations on intellectual property rights.

With authors from eleven different countries presenting case studies of national experiences in Africa, Asia and the Americas, the book analyzes national strategies to promote pharmaceutical innovation, while at the same time assuring widespread access to medicines through generic pharmaceutical production and generic pharmaceutical importation. The expert chapters focus on patents as well as an array of regulatory instruments, including pricing and drug registration policies.

Presenting in-depth analysis and original empirical research, this book will strongly appeal to academics and students of intellectual property, international health, international political economy, international development and law.

Contributors: T. Andia, M. Bourassa Forcier, M. Flynn, P. Gehl Sampath, S. Guennif, A. Guzman, H. Klug, G. Krikorian, N. Lalitha, J.-F. Morin, K.C. Shadlen, L. Shi, M. Watanabe

Edited by Kenneth C. Shadlen, London School of Economics and Political Science, UK, Samira Guennif, Université Paris 13, France, Alenka Guzmán, Autonomous Metropolitan University-Iztapalapa, Mexico and Narayanan Lalitha, Gujarat Institute of Development Research, India

Contents:

1. Globalization, Intellectual Property Rights, and Pharmaceuticals: Meeting the Challenges to Addressing Health Gaps in the New International Environment
Kenneth C. Shadlen, Samira Guennif, Alenka Guzmán and N. Lalitha

2. Pharmaceutical Production and Access to Essential Medicines in South Africa
Heinz Klug

3. Intellectual Property and Access to Medicines: Paradoxes in Moroccan Policy
Gaëlle Krikorian

4. The Invisible Threat: Trade, Intellectual Property, and Pharmaceutical Regulations in Colombia
Tatiana Andia

5. The Challenges of Constructing Pharmaceutical Capabilities and Promoting Access to Medicines in Mexico under TRIPS
Alenka Guzmán

6. Corporate Power and State Resistance: Brazil’s Use of TRIPS Flexibilities for its National AIDS Program
Matthew Flynn

7. The Politics of Patents and Drugs in Brazil and Mexico: The Industrial Bases of Health Policies
Kenneth C. Shadlen

8. Pharmaceutical Patent Policy in Developing Countries: Learning from the Canadian Experience
Jean-Frédéric Morin and Mélanie Bourassa Forcier

9. Access to Indian Generic Drugs: Emerging Issues
N. Lalitha

10. Sufficient but Expensive Drugs: A Double-Track System that Facilitated Supply Capability in China
Mariko Watanabe and Luwen Shi

11. Access to Essential Drugs in Thailand: Intellectual Property Rights and Other Institutional Matters Affecting Public Health in a Developing Country
Samira Guennif

12. The TRIPS Agreement and Health Innovation in Bangladesh
Padmashree Gehl Sampath

Index

Erscheint lt. Verlag	30.11.2011
Verlagsort	Cheltenham
Sprache	englisch
Maße	156 x 234 mm
Themenwelt	Studium ► Querschnittsbereiche ► Prävention / Gesundheitsförderung
	Recht / Steuern ► EU / Internationales Recht
	Recht / Steuern ► Privatrecht / Bürgerliches Recht ► Medizinrecht
	Recht / Steuern ► Wirtschaftsrecht ► Urheberrecht
	Wirtschaft
ISBN-10	1-84980-014-6 / 1849800146
ISBN-13	978-1-84980-014-3 / 9781849800143
Zustand	Neuware